Read more

Researchers at Helmholtz Munich, the Technical University of Munich (TUM), the Stowers Institute for Medical Research, and the University of Oxford, have developed an AI-based model that not only traces the developmental paths of individual cells,…

Read more

Helmholtz Zentrum München
Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Ingolstädter Landstraße 1
85764 Neuherberg
Deutschland
 

Verhandlungsverfahren ohne TW / Negotiated procedure without prior publication

…

Read more

Until now, studying the genetic processes in cells required destroying them - making it impossible to observe these processes over extended periods of time. A team from Helmholtz Munich and the Technical University of Munich (TUM) has developed a new…

Read more

Dr. Teresa Rodriguez-Calvo from Helmholtz Munich has been awarded two prestigious grants from Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization. The funding will support two innovative projects at the…

Read more

As part of the Fr1da study, “Early detection and early treatment of type 1 diabetes”, led by researchers at the Institute of Diabetes Research at Helmholtz Munich, families can have their children aged two to ten tested for an early stage of type 1…

Read more

Read more

Read more

Read more

Read more

Read more

Read more

Regular exercise is a key component of a healthy lifestyle and is particularly important for preventing type 2 diabetes and other non-communicable diseases. Nevertheless, many people find it difficult to incorporate sufficient exercise into their…

Read more

A team led by metabolism researcher Prof Timo D. Müller at Helmholtz Munich has developed a new approach for treating obesity and type 2 diabetes: a hybrid molecule uses the well-known GLP-1/GIP signalling pathway as a “door opener” and delivers an…

Read more

Prof. Marcus Conrad, Director of the Institute of Metabolism and Cell Death at Helmholtz Munich, has been honored with the 54th Fondation ARC Léopold Griffuel Award for Translational and Clinical Research. The award recognizes his pioneering…

Read more

Prof. Anette-Gabriele Ziegler from Helmholtz Munich has been named the recipient of the 58th Claude Bernard Prize, the highest honor awarded by the European Association for the Study of Diabetes (EASD). The prize recognizes her outstanding leadership…

Read more

Read more

A new review in Cell by Helmholtz Munich researchers and international collaborators reframes regulated cell death as a roadmap for the next generation of precision oncology. Publication coincides with the 25th anniversary of the seminal Hallmarks of…

Read more

Physician and researcher Prof. Antje Körner has been elected as a new member of the Saxon Academy of Sciences and Humanities in Leipzig. On April 10, 2026, she was officially admitted to the Academy’s Mathematical and Natural Sciences Class during…

Read more

The project “2036 – Healthy with AI?” explores how artificial intelligence will shape healthcare in the future – from prevention and diagnosis to therapy. The goal is to make the potential, limitations, and societal impacts of AI applications in…

Read more

Read more

Read more

Read more

Read more

Read more

Read more

Read more

Helmholtz Zentrum München
Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Ingolstädter Landstraße 1
85764 Neuherberg
Deutschland
 

Verhandlungsverfahren ohne TW / Negotiated procedure without prior publication

…

Read more

Read more

Prof. Marcus Conrad, Director of the Institute of Metabolism and Cell Death at Helmholtz Munich was awarded the German Cancer Award 2026 in the category “Experimental Research”, together with Prof. José Pedro Friedmann Angeli of the University of…

Read more